Editorial
Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:945-947
.
(28 August 2020)
Adjuvant EGFR-TKIs-based therapy: are we ready?
Translational Lung Cancer Research
2020;
9
(4)
:948-950
.
(28 August 2020)
Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies?
Translational Lung Cancer Research
2020;
9
(4)
:951-955
.
(28 August 2020)
Biomarkers predictive value in early stage non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:956-959
.
(28 August 2020)
Melting the tip of the iceberg: bronchoscopic-guided transbronchial microwave ablation
Translational Lung Cancer Research
2020;
9
(4)
:960-963
.
(28 August 2020)
Adjuvant TKI treatment of EGFR-mutant lung cancer—already ripe for decision?
Translational Lung Cancer Research
2020;
9
(4)
:964-966
.
(28 August 2020)
The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
Translational Lung Cancer Research
2020;
9
(4)
:967-970
.
(28 August 2020)
Consensus
Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS)
Translational Lung Cancer Research
2020;
9
(4)
:971-987
.
(28 August 2020)
Original Article
Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non- small cell lung cancer (NSCLC) patients
Translational Lung Cancer Research
2020;
9
(4)
:988-999
.
(28 August 2020)
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives
Translational Lung Cancer Research
2020;
9
(4)
:1000-1014
.
(28 August 2020)
Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
Translational Lung Cancer Research
2020;
9
(4)
:1015-1028
.
(28 August 2020)
Molecular differences across invasive lung adenocarcinoma morphological subgroups
Translational Lung Cancer Research
2020;
9
(4)
:1029-1040
.
(28 August 2020)
Does size matter? —a population-based analysis of malignant pleural mesothelioma
Translational Lung Cancer Research
2020;
9
(4)
:1041-1052
.
(28 August 2020)
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors
Translational Lung Cancer Research
2020;
9
(4)
:1053-1066
.
(28 August 2020)
An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1067-1073
.
(28 August 2020)
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1074-1083
.
(28 August 2020)
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes
Translational Lung Cancer Research
2020;
9
(4)
:1084-1092
.
(28 August 2020)
Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients
Translational Lung Cancer Research
2020;
9
(4)
:1093-1100
.
(28 August 2020)
Cancer-associated changes of emotional brain network in non-nervous system metastatic non-small cell lung cancer patients: a structural connectomic diffusion tensor imaging study
Translational Lung Cancer Research
2020;
9
(4)
:1101-1111
.
(28 August 2020)
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(4)
:1112-1123
.
(28 August 2020)
A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians
Translational Lung Cancer Research
2020;
9
(4)
:1124-1137
.
(28 August 2020)
LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1
Translational Lung Cancer Research
2020;
9
(4)
:1138-1148
.
(28 August 2020)
The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1149-1158
.
(28 August 2020)
Radiological manifestations, histological features and surgical outcomes of pulmonary meningothelial proliferation: a case series and rethinking
Translational Lung Cancer Research
2020;
9
(4)
:1159-1168
.
(28 August 2020)
Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program
Translational Lung Cancer Research
2020;
9
(4)
:1169-1179
.
(28 August 2020)
Recent trends in use of adjuvant chemotherapy in elderly stage II– III non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1180-1186
.
(28 August 2020)
Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis
Translational Lung Cancer Research
2020;
9
(4)
:1187-1201
.
(28 August 2020)
Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
Translational Lung Cancer Research
2020;
9
(4)
:1202-1211
.
(28 August 2020)
3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(4)
:1212-1224
.
(28 August 2020)
Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(4)
:1225-1234
.
(28 August 2020)
Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study
Translational Lung Cancer Research
2020;
9
(4)
:1235-1246
.
(28 August 2020)
Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion
Translational Lung Cancer Research
2020;
9
(4)
:1247-1257
.
(28 August 2020)
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
Translational Lung Cancer Research
2020;
9
(4)
:1258-1267
.
(28 August 2020)
Dose-response relationship of stereotactic body radiotherapy for ultracentral tumor and comparison of efficacy with central tumor: a meta-analysis
Translational Lung Cancer Research
2020;
9
(4)
:1268-1284
.
(28 August 2020)
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study
Translational Lung Cancer Research
2020;
9
(4)
:1285-1301
.
(28 August 2020)
Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
Translational Lung Cancer Research
2020;
9
(4)
:1302-1323
.
(28 August 2020)
18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1324-1332
.
(28 August 2020)
Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1333-1342
.
(28 August 2020)
PD-L1 as a prognostic biomarker in surgically resectable non- small cell lung cancer: a meta-analysis
Translational Lung Cancer Research
2020;
9
(4)
:1343-1360
.
(28 August 2020)
High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1361-1378
.
(28 August 2020)
Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell- maintenance factors and inducing apoptosis via the Hedgehog signaling blockade
Translational Lung Cancer Research
2020;
9
(4)
:1379-1396
.
(28 August 2020)
Predicting the invasiveness of lung adenocarcinomas appearing as ground-glass nodule on CT scan using multi-task learning and deep radiomics
Translational Lung Cancer Research
2020;
9
(4)
:1397-1406
.
(28 August 2020)
Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
Translational Lung Cancer Research
2020;
9
(4)
:1407-1421
.
(28 August 2020)
Looking through the eyes of the multidisciplinary team: the design and clinical evaluation of a decision support system for lung cancer care
Translational Lung Cancer Research
2020;
9
(4)
:1422-1432
.
(28 August 2020)
Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1433-1440
.
(28 August 2020)
Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1441-1451
.
(28 August 2020)
Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion
Translational Lung Cancer Research
2020;
9
(4)
:1452-1463
.
(28 August 2020)
Analysis of the clinical effect of osimertinib on 90 cases with advanced lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(4)
:1464-1471
.
(28 August 2020)
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1472-1482
.
(28 August 2020)
CD39: the potential target in small cell lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1483-1495
.
(28 August 2020)
Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
Translational Lung Cancer Research
2020;
9
(4)
:1496-1506
.
(28 August 2020)
A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1507-1515
.
(28 August 2020)
COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study
Translational Lung Cancer Research
2020;
9
(4)
:1516-1527
.
(28 August 2020)
Brief Report
Rates of positive lung cancer screening examinations in academic versus community practice
Translational Lung Cancer Research
2020;
9
(4)
:1528-1532
.
(28 August 2020)
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab
Translational Lung Cancer Research
2020;
9
(4)
:1533-1542
.
(28 August 2020)
Review Article
Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients
Translational Lung Cancer Research
2020;
9
(4)
:1543-1553
.
(28 August 2020)
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Translational Lung Cancer Research
2020;
9
(4)
:1554-1568
.
(28 August 2020)
Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers
Translational Lung Cancer Research
2020;
9
(4)
:1569-1584
.
(28 August 2020)
Case Report
Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report
Translational Lung Cancer Research
2020;
9
(4)
:1585-1590
.
(28 August 2020)
Editorial Commentary
First-line cytotoxic chemotherapy regimen for non-small cell lung cancer in the elderly population: plus ça change
Translational Lung Cancer Research
2020;
9
(4)
:1591-1594
.
(28 August 2020)
PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC
Translational Lung Cancer Research
2020;
9
(4)
:1595-1598
.
(28 August 2020)
Hormone gene signature guides a novel therapeutic opportunity to improve sensitivity to HER family inhibition in lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1599-1605
.
(28 August 2020)
Alternative splicing of HER2: a novel mediator of EGFR TKI resistance
Translational Lung Cancer Research
2020;
9
(4)
:1606-1612
.
(28 August 2020)
Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back
Translational Lung Cancer Research
2020;
9
(4)
:1613-1616
.
(28 August 2020)
Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?
Translational Lung Cancer Research
2020;
9
(4)
:1617-1622
.
(28 August 2020)
Letter to the Editor
Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
Translational Lung Cancer Research
2020;
9
(4)
:1623-1624
.
(28 August 2020)
Editorial on Lung Cancer Multidisciplinary Care1
Multidisciplinary team care in lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1625-1628
.
(28 August 2020)
Review Article on Lung Cancer Multidisciplinary Care1
Optimizing lung cancer MDT data for maximum clinical impact—a scoping literature review
Translational Lung Cancer Research
2020;
9
(4)
:1629-1638
.
(28 August 2020)
A review on the impact of lung cancer multidisciplinary care on patient outcomes
Translational Lung Cancer Research
2020;
9
(4)
:1639-1653
.
(28 August 2020)
Accuracy of lung cancer staging in the multidisciplinary team setting
Translational Lung Cancer Research
2020;
9
(4)
:1654-1666
.
(28 August 2020)
Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps
Translational Lung Cancer Research
2020;
9
(4)
:1667-1679
.
(28 August 2020)
Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team
Translational Lung Cancer Research
2020;
9
(4)
:1680-1689
.
(28 August 2020)
Multidisciplinary team care in advanced lung cancer
Translational Lung Cancer Research
2020;
9
(4)
:1690-1698
.
(28 August 2020)
Earlier multidisciplinary palliative care intervention for people with lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2020;
9
(4)
:1699-1709
.
(28 August 2020)
Disclosure:
1. The series “Lung Cancer Multidisciplinary Care” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Emily Stone served as the unpaid Guest Editor of the series.
